@article{article, title  = {{Cost effectiveness of ranibizumab vs aflibercept vs bevacizumab for the treatment of macular oedema due to central retinal vein occlusion: the LEAVO study}},

 publisher = {{Springer}},

 url = {{http://eprints.whiterose.ac.uk/173442/ }},

 year = {{2021}},

 month = {{4}},

 author = {{Pennington R and Alshreef A and Flight L and Metry A and Poku E and Hykin P and Sivaprasad S and Prevost AT and Vasconcelos JC and Murphy C and Kelly J et al}},

 doi = {{10.1007/s40273-021-01026-5}},

 journal = {{PharmacoEconomics}},

 note = {{Accessed on 2024/09/19}}}